Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 30
2018
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,233
+15.0%
|
-
|
|
Jul 30
2018
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
9,730
+12.04%
|
-
|
|
Jul 30
2018
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
10,478
+16.75%
|
-
|
|
Jul 28
2018
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
10,038
-14.95%
|
$883,344
$88.66 P/Share
|
|
Jun 22
2018
|
Carol A Surface EVP, Chief HR Officer |
BUY
Discretionary transaction
|
Indirect |
985
+32.41%
|
$84,710
$86.81 P/Share
|
|
Jun 20
2018
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,527
-8.99%
|
$561,322
$86.13 P/Share
|
|
Jun 12
2018
|
Robert C Pozen Director |
SELL
Bona fide gift
|
Direct |
11,625
-16.33%
|
-
|
|
Jun 11
2018
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
8,910
-14.67%
|
$766,260
$86.82 P/Share
|
|
Jun 08
2018
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
11,500
-9.79%
|
$1,000,500
$87.13 P/Share
|
|
May 01
2018
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-0.82%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-2.08%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-6.24%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.7%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
Shirley A Jackson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.57%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
Robert C Pozen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-0.86%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-2.0%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.03%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-8.78%
|
$49,896
$81.01 P/Share
|
|
May 01
2018
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-1.25%
|
$49,896
$81.01 P/Share
|
|
Apr 30
2018
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+2.84%
|
-
|
|
Apr 30
2018
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+6.87%
|
-
|
|
Apr 30
2018
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+18.11%
|
-
|
|
Apr 30
2018
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+5.7%
|
-
|
|
Apr 30
2018
|
Shirley A Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+5.28%
|
-
|
|
Apr 30
2018
|
Robert C Pozen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+2.95%
|
-
|
|
Apr 30
2018
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+11.95%
|
-
|
|
Apr 30
2018
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+6.61%
|
-
|
|
Apr 30
2018
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+3.52%
|
-
|
|
Apr 30
2018
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+23.74%
|
-
|
|
Apr 30
2018
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+4.24%
|
-
|
|
Apr 17
2018
|
Denise M Oleary Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+2.68%
|
$79,500
$50.34 P/Share
|
|
Mar 13
2018
|
James T Lenehan Director |
SELL
Open market or private sale
|
Direct |
1,306
-2.7%
|
$108,398
$83.56 P/Share
|
|
Mar 13
2018
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+3.18%
|
$79,500
$50.34 P/Share
|
|
Mar 05
2018
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40,338
-51.62%
|
$3,186,702
$79.74 P/Share
|
|
Mar 05
2018
|
Carol A Surface EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,620
+18.53%
|
$2,965,820
$61.06 P/Share
|
|
Mar 05
2018
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
12,479
-29.7%
|
$973,362
$78.36 P/Share
|
|
Mar 02
2018
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
12,000
-22.22%
|
$936,000
$78.0 P/Share
|
|
Feb 18
2018
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
1,472
-3.47%
|
$122,176
$83.31 P/Share
|
|
Jan 09
2018
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
78,526
-40.14%
|
$6,753,236
$86.21 P/Share
|
|
Jan 09
2018
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
81,364
+19.08%
|
$2,929,104
$36.21 P/Share
|
|
Jan 05
2018
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
26,158
-28.44%
|
$2,223,430
$85.0 P/Share
|
|
Jan 05
2018
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
26,158
+22.14%
|
$1,621,796
$62.76 P/Share
|
|
Dec 15
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
16,000
-15.26%
|
$1,312,000
$82.82 P/Share
|
|
Dec 01
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,249
-3.9%
|
$344,169
$81.27 P/Share
|
|
Nov 16
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
16,000
-12.79%
|
$1,264,000
$79.02 P/Share
|
|
Oct 28
2017
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,602
-13.77%
|
$696,762
$81.3 P/Share
|
|
Oct 16
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
16,000
-11.38%
|
$1,248,000
$78.03 P/Share
|
|
Sep 15
2017
|
Omar Ishrak Executive Chairman |
SELL
Open market or private sale
|
Direct |
140,407
-21.0%
|
$11,372,967
$81.63 P/Share
|
|
Sep 15
2017
|
Omar Ishrak Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+13.01%
|
$3,800,000
$38.81 P/Share
|
|
Aug 25
2017
|
Denise M Oleary Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,010
+1.79%
|
$52,520
$52.84 P/Share
|